Preclinical Data Supporting Use of CAR T-Cell Therapy in Multiple Myeloma
June 11th 2018Noopur S. Raje, MD, a medical oncologist at Massachusetts General Hospital, discusses chimeric antigen receptor T-cell therapy in patients with multiple myeloma. This therapy has been an exciting advancement in both hematology as well as solid tumors, she notes.